«Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration». 2024. Ukrainian Journal of Ophthalmology , вип. 3 (Липень): 28-32. https://doi.org/10.31288/oftalmolzh202432832.